Clinical Trials Browser

Phase 3 × INDUSTRY × tafasitamab × Clear all

NCT05429268 2026-05-05

firmMIND

Phase 3 Active not recruiting

Lymphoma, Large B-Cell, Diffuse

NCT04824092 2026-04-01

frontMIND

Phase 3 Active not recruiting

Lymphoma, Large B-Cell, Diffuse

NCT04680052 2025-12-22

InMIND

Phase 3 Active not recruiting

654 enrolled 40 charts 1 FDA

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone